INDIANAPOLIS--(YourEncore, a leading provider of expert solutions to the life sciences and consumer product industries, today launched a new solution that will help pharmaceutical companies make more informed decisions about whether and how to proceed with Phase III trials.)--
“Drug companies today are under extreme pressure to deliver the next blockbuster”
“The stakes couldn’t be higher, yet nearly four in 10 drugs in Phase III fail to get approval,” said Lisa M. Arbogast, YourEncore’s VP for Life Sciences. “Our Independent Challenge Teams (ICTs) provide an unbiased expert perspective that can help a company avoid failures during this critical stage of testing.”
YourEncore hand-selects teams of leading clinical, regulatory, commercial and market access experts for each project based on disease and therapeutic areas of expertise. After a rigorous study of the data, the team assesses the likelihood of success in Phase III and may recommend changes in protocol design, labeling and claims to increase the odds of approval.
Companies typically spend hundreds of millions of dollars in Phase III, while facing intense scrutiny from Wall Street and regulators. As a result, failures can have a devastating impact on a drug-maker’s reputation and financial position. YourEncore provides critical insights that allow companies to make better-informed go/no-go decisions prior to entering Phase III.
A company’s in-house researchers may spend years developing a compound and often have significant personal and professional investments in its success. ICTs, whose members average 25 years of experience, can provide an unbiased, fresh look at a drug before it enters the most costly and high profile phase of trials.
“Drug companies today are under extreme pressure to deliver the next blockbuster,” said Arbogast. “YourEncore provides a level of expertise and objectivity that is critical to success in the regulatory process and the marketplace.”
Indianapolis-based YourEncore accelerates innovation and growth for companies in the life sciences and consumer product industries. The company’s 7,500+ veteran-level experts include top-flight professionals, with an average of 25 years of industry experience. By providing perfectly-matched expertise and flexible solutions, YourEncore helps research, develop and commercialize products for Procter & Gamble, Lilly, Boeing, General Mills and nearly 70 other global Fortune 500 leaders. For more information, visit www.yourencore.com and follow facebook/yourencore.